Dermapharm Holding SE
A manufacturer of patent-free branded pharmaceuticals and healthcare products.
DMP | F
Overview
Corporate Details
- ISIN(s):
- DE000A2GS5D8
- LEI:
- 5299009F0KNZINQQQK37
- Country:
- Germany
- Address:
- Lil-Dagover-Ring 7, 82031 Grünwald
- Sector:
- Manufacturing
Description
Dermapharm Holding SE is a manufacturer of branded pharmaceuticals and healthcare products, with a focus on the patent-free segment. The company operates an integrated business model that encompasses the entire value chain, including in-house research and development, production, and distribution. A dedicated pharmaceutical sales force manages the marketing and sales of its brand products. Dermapharm maintains a diversified portfolio concentrated on selected therapeutic areas, allowing it to establish strong market positions. The company operates several production, development, and distribution sites to support its operations and international expansion.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-10 14:30 |
Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy
|
English | 6.0 KB | ||
| 2025-11-13 07:30 |
Stable earnings despite portfolio adjustment - 2025 guidance confirmed, strong…
|
English | 24.7 KB | ||
| 2025-11-13 00:00 |
Q3 statement / Q3 financial report 2025
|
English | 350.5 KB | ||
| 2025-11-05 13:48 | English | 4.0 KB | |||
| 2025-11-03 11:45 |
Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy
|
English | 6.3 KB | ||
| 2025-08-26 07:30 |
Dermapharm confirms stable business development in H1 2025 and records EBITDA g…
|
English | 25.4 KB | ||
| 2025-08-26 00:00 |
Half-yearly financial report 2025
|
English | 1.5 MB | ||
| 2025-08-18 09:26 | English | 4.0 KB | |||
| 2025-08-12 07:30 |
Dermapharm Holding SE remains on projected growth trajectory in Q2 2025
|
English | 15.1 KB | ||
| 2025-07-04 16:18 |
Dermapharm Holding SE: Wilhelm Beier, buy
|
English | 5.8 KB | ||
| 2025-07-01 12:30 | German | 12.3 KB | |||
| 2025-06-27 14:40 | English | 12.0 KB | |||
| 2025-06-26 17:43 |
Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of…
|
English | 10.9 KB | ||
| 2025-06-24 16:46 |
Dermapharm Holding SE: Dr. Andreas Eberhorn, buy
|
English | 5.8 KB | ||
| 2025-06-05 12:29 |
Dermapharm Holding SE: Anja Schorn, buy
|
English | 6.2 KB |
Automate Your Workflow. Get a real-time feed of all Dermapharm Holding SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Dermapharm Holding SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Dermapharm Holding SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-12-30 | Themis Beteiligungs-Aktiengesellschaft | Close relation | Buy | None | 54,530,000.00 EUR |
| 2024-12-30 | Beier, Wilhelm | Supervisory board | Buy | None | 3,895,000.00 EUR |
| 2024-11-15 | Themis Beteiligungs-Aktiengesellschaft | Close relation | Buy | None | 6,464,000.00 EUR |
| 2024-11-11 | Feldmeier, Dr. Hans-Georg | Board | Buy | None | 95,185.00 EUR |
| 2024-11-05 | Dreibholz, Christof | Board | Buy | None | 27,720.00 EUR |
| 2024-10-23 | Lanz, Susanne Gertrud Pia | Close relation | Buy | None | 19,704.55 EUR |
| 2024-08-29 | Themis Beteiligungs-Aktiengesellschaft | Close relation | Buy | None | 29,954,600.00 EUR |
| 2024-06-11 | Lanz, Susanne Gertrud Pia | Close relation | Buy | None | 101,778.57 EUR |
| 2024-05-22 | Themis Beteiligungs-Aktiengesellschaft | Close relation | Buy | None | 8,577,500.00 EUR |
| 2023-06-27 | Feldmeier, Dr. Hans-Georg | Board | Buy | None | 99,902.36 EUR |
Peer Companies
